Most studies have examined the expression of HIF-1α suggesting that it would be associated with higher pathologic grade and tumor stage, higher MVD (microvascular density), higher rate of metastasis, poorer overall survival, poorer disease-free survival and poor response to chemotherapy [48,50,51,58,59,60,61,62,63]. This evidence concerns the gene HIF1A and neoplasm.